Huiyuan Li
Changzhi Medical College(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)First People's Hospital of Yunnan Province(CN)Shanxi Jincheng Anthracite Mining Group (China)(CN)Institute of Hematology & Blood Diseases Hospital(CN)
Publications by Year
Research Areas
Platelet Disorders and Treatments, Blood groups and transfusion, Myeloproliferative Neoplasms: Diagnosis and Treatment, Cell Adhesion Molecules Research, Immune Cell Function and Interaction
Most-Cited Works
- → Click Chemistry in Peptide-Based Drug Design(2013)183 cited
- → C-terminal peptides coassemble into Aβ42 oligomers and protect neurons against Aβ42-induced neurotoxicity(2008)183 cited
- → Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system(2018)102 cited
- → Aβ(39–42) Modulates Aβ Oligomerization but Not Fibril Formation(2011)79 cited
- → Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial(2022)71 cited
- → Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters immunomodulatory activity through the downregulation of PD-L1(2023)66 cited